By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Elliott Management Statement on Toyota Industries Corporation
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > News > Elliott Management Statement on Toyota Industries Corporation
Elliott Management Statement on Toyota Industries Corporation
News

Elliott Management Statement on Toyota Industries Corporation

Last updated: 03/02/2026 11:36 AM
Published: 03/02/2026
Share
SHARE

Toyota Fudosan’s tender offer drastically undervalues the Company

- Advertisement -

Elliott does not intend to tender its shares into the Revised TOB at the current terms and strongly encourages other shareholders not to tender

- Advertisement -

LONDON, Feb. 2, 2026 /PRNewswire/ — Elliott Investment Management L.P. and Elliott Advisors (UK) Limited (“Elliott”), which advise funds that together have a significant investment in Toyota Industries Corporation (“Toyota Industries” or the “Company”) and are the Company’s largest independent shareholder, today issued the following statement:

- Advertisement -

Elliott notes the non-binding statement issued today by an affiliate of Toyota Fudosan Co., Ltd. (“Toyota Fudosan”). Elliott maintains its position that the revised tender offer by Toyota Fudosan at ¥18,800 per share (the “Revised TOB”) very significantly undervalues Toyota Industries, as Elliott demonstrates in its public materials. Elliott continues to strongly disagree with Toyota Fudosan’s assertion that the Revised TOB price “reflects the intrinsic value of the Target Company“.

- Advertisement -

Elliott does not intend to tender its shares into the Revised TOB at the current terms and strongly encourages other shareholders not to tender.

- Advertisement -

Elliott’s previously released public materials can be found at https://elliottletters.com. 

- Advertisement -

About Elliott

- Advertisement -

Elliott Investment Management L.P. (together with its affiliates, “Elliott”) manages approximately $76.1 billion of assets as of June 30, 2025. Founded in 1977, it is one of the oldest funds under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Investment Management L.P.

- Advertisement -

Investor Contacts:

- Advertisement -

Okapi Partners LLC
New York: Pat McHugh
T:+1 212 297 0720
Toll Free: (877) 629-6357
London: Christian Jacques
T: +44 20 3031 6613
TICO@okapipartners.com

- Advertisement -

Media Contacts:

- Advertisement -

London
Stijn van de Grampel
Elliott Advisors (UK) Limited
T: +44 20 3009 1061
svdgrampel@elliottadvisors.co.uk

- Advertisement -

New York
Stephen Spruiell
Elliott Investment Management L.P.
T: +1 (212) 478-2017
sspruiell@elliottmgmt.com

- Advertisement -

Tokyo
Brett Wallbutton
Ashton Consulting
T: +81 (0) 3 5425-7220
b.wallbutton@ashton.jp

- Advertisement -

Logo – https://mma.prnewswire.com/media/2705826/5748241/Elliott_WhiteText_Green_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/elliott-management-statement-on-toyota-industries-corporation-302676899.html

- Advertisement -
NYSE Content Advisory: Pre-Market Update + Seven of the Top 10 IPOs in 2025 List on NYSE
Basecamp Research Launches Trillion Gene Atlas to Scale AI-Designed Therapeutics
China Southern Power Grid Marks Its First Delegation Appearance at COP30, Showcasing Sustainability and Low-Carbon Initiatives
Ooma Receives Frost & Sullivan’s 2026 North American Competitive Strategy Leadership Recognition for Excellence in POTS-Replacement Solution Innovation
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
TAGGED:corporation:elliottindustriesmanagementnewsstatementtoyota
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Biz2X Collaborates with AWS to Launch Industry-First Agentic AI Digital Lending Solution
News

Biz2X Collaborates with AWS to Launch Industry-First Agentic AI Digital Lending Solution

07/10/2025
HDFC Life Celebrates 25 Years of Trust with Branding of Mahalaxmi Metro Station on Mumbai’s Metro Line 3
The largest pharma show in Asia makes its return to Shanghai this June 2026
DEKRA reflects on its anniversary year: A stable foundation today, a clear direction for tomorrow
Flipster and Aptos Foundation Partner to Drive Stablecoin Adoption and Unlock Multichain Opportunities
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?